The Therapeutic Development Network (TDN), the industry leader in the development of cystic fibrosis treatments, has ranked the WVU Medicine adult and pediatric cystic fibrosis programs 13th out of 90 TDN centers for interventional study enrollment and seventh out of 59 centers for observational studies.